Patents by Inventor James Diakur

James Diakur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dual antiplatelet/anticoagulant pyridoxine analogs
    Patent number: 7812037
    Abstract: Compounds with antiplatelet aggregation and anticoagulant characteristics for the treatment of cardiovascular, cerebrovascular, and cardiovascular related diseases and symptoms, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxine and/or substituted pyridoxine analogs.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: October 12, 2010
    Assignee: Medicure International, Inc.
    Inventors: Wasimul Haque, James Diakur, Vinh Pham, Atiq Rehman, Tara Whitney, Mohammed Omar, Seng Yi, A. Qasim Khan
  • Substituted Pyridoxines As Anti-Platelet Agents
    Publication number: 20080306108
    Abstract: Compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising a pyridoxine analogue.
    Type: Application
    Filed: June 6, 2008
    Publication date: December 11, 2008
    Applicant: MEDICURE INTERNATIONAL INC.
    Inventors: Wasimul Haque, James Diakur, Vinh Pham, Wenlian Zhang
  • Aryl sulfonic pyridoxines as antiplatelet agents
    Patent number: 7459468
    Abstract: Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: December 2, 2008
    Assignee: Medicure International, Inc.
    Inventors: Wasimul Haque, James Diakur
  • Aryl Sulfonic Pyridoxines as Antiplatelet Agents
    Publication number: 20070142270
    Abstract: Aryl sulfonic pyridoxine compounds with inhibition of serine protease activity and antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related diseases are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.
    Type: Application
    Filed: February 7, 2007
    Publication date: June 21, 2007
    Inventors: Wasimul Haque, James Diakur
  • Novel drug delivery compositions
    Publication number: 20070021380
    Abstract: The present invention provides for a novel molecules useful for delivery of compounds to a mammal, more particularly for the intracellular delivery of nucleotides, nucleotide analogues or compounds with a heterocyclic base. Also provided for are novel therapeutic complexes comprising novel molecules complexed with nucleotide analogues or heterogeneous or homogenous oligomers comprised of nucleotide analogues.
    Type: Application
    Filed: July 24, 2006
    Publication date: January 25, 2007
    Inventors: Leonard Wiebe, James Diakur
  • Novel heteroaryl phosphonates as cardioprotective agents
    Publication number: 20060241083
    Abstract: This invention teaches a-substituted phosphonates, their preparation, pharmaceutical compositions thereof, biologically acceptable salts thereof, and methods for treating various disorders using such compositions.
    Type: Application
    Filed: March 15, 2004
    Publication date: October 26, 2006
    Applicant: Medicure International Inc.
    Inventors: James Diakur, Wasimul Haque, Wenlian Zhang, Junzhi Yao, Vinh Pham
  • Dual antiplatelet/anticoagulant pyridoxine analogs
    Publication number: 20060094761
    Abstract: Compounds with antiplatelet aggregation and anticoagulant characteristics for the treatment of cardiovascular, cerebrovascular, and cardiovascular related diseases and symptoms, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxine and/or substituted pyridoxine analogs.
    Type: Application
    Filed: October 28, 2005
    Publication date: May 4, 2006
    Inventors: Wasimul Haque, James Diakur, Vinh Pham, Atiq Rehman, Tara Whitney, Mohammed Omar, Seng Yi, A. Khan
  • Aryl sulfonic pyridoxines as antiplatelet agents
    Publication number: 20060094748
    Abstract: Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 4, 2006
    Inventors: Wasimul Haque, James Diakur
  • Substituted pyridoxines as anti-platelet agents
    Publication number: 20060094749
    Abstract: Compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising a pyridoxine analogue.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 4, 2006
    Inventors: Wasimul Haque, James Diakur, Vinh Pham, Wenlian Zhang
  • Novel heteroaryl phosphonates as cardioprotective agents
    Publication number: 20040186077
    Abstract: The invention teaches compound of general formula: 1
    Type: Application
    Filed: March 17, 2003
    Publication date: September 23, 2004
    Applicant: Medicure International Inc.
    Inventors: James Diakur, Wasimul Haque, Wenlian Zhang, Junzhi Yao, Vinh Pham
  • Fluorocyclosaccharide drug delivery systems
    Patent number: 5739121
    Abstract: Novel fluorine-containing cyclic saccharide compounds, in particular fluorocyclodextrin compounds, and drug inclusion complexes of these compounds, as well as methods for preparation of the novel fluorine-containing cyclic saccharide compounds, including fluorocyclodextrins, and drug inclusion complexes of the compounds. In addition, methods for following the disposition and fate in vivo of drug inclusion complexes of the invention.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: April 14, 1998
    Assignee: University of Alberta
    Inventors: Leonard I. Wiebe, James Diakur